SDS-PAGE Protocol & Troubleshooting

Solutions and Reagents Workflow Troubleshooting Products with Tested Data

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is a fundamental technique used to separate proteins based on their molecular weight. This method is essential for protein analysis, providing information about protein size, purity, and relative abundance in complex biological samples.

Here we go over the SDS-PAGE protocols, including the reagents, solutions, procedures, and troubleshooting advice for typical issues. Our aim is to help you understand and explain the protocol processes and take full advantage of the detailed protocols for western blot.

Solutions and Reagents

Stages Solutions and Reagents
Preparation Sample buffer, SDS solution, reducing agent (DTT or β-mercaptoethanol)
Gel Preparation Acrylamide/bis-acrylamide solution, stacking gel buffer, resolving gel buffer, APS, TEMED
Electrophoresis Running buffer, molecular weight markers
Visualization Staining solution (Coomassie or silver stain), destaining solution

Workflow

Workflow of SDS-PAGE

1. Gel Preparation

Prepare the resolving gel solution with appropriate acrylamide concentration based on protein size range. Add APS and TEMED to initiate polymerization. Once set, prepare and pour the stacking gel on top. Insert the comb immediately and allow to polymerize completely.

2. Sample Electrophoresis

Mix protein samples with sample buffer containing SDS and reducing agent. Heat samples at 95-100°C for 3-5 minutes to denature proteins. Centrifuge briefly to remove any precipitates. Load samples and molecular weight markers into gel wells.

3. Electrophoresis

Fill the electrophoresis chamber with running buffer. Connect to power supply and run at appropriate voltage. Monitor the dye front and stop when it reaches the bottom of the gel.

4. Staining and Destaining

Remove gel from glass plates carefully. Stain with Coomassie Brilliant Blue or silver stain. Destain until protein bands are clearly visible against a clear background. Document and analyze results.

Troubleshooting

Despite the simplicity of the SDS-PAGE, problems may still arise such as poor band resolution. For some of the problems that may occur, we provide the following troubleshooting guide.

  • Poor Band Resolution

Common causes include incorrect acrylamide concentration for target protein size - select appropriate percentage based on molecular weight range; running the gel at too high voltage causing heat generation - reduce voltage or use cooling system; buffer depletion during long runs - replace with fresh buffer periodically; old or improperly stored acrylamide solutions affecting polymerization - use fresh reagents stored properly; inadequate sample denaturation - ensure complete heating and SDS binding.

  • Smeared or Distorted Bands

Sample overloading can overwhelm gel capacity - reduce protein amount loaded; presence of nucleic acids or lipids in samples - perform additional purification steps; incomplete protein solubilization - optimize sample buffer composition or add solubilizing agents; high salt concentration interferes with migration - desalt or dilute samples; trapped air bubbles affect protein migration - degas solutions and pour carefully.

  • Vertical Streaking

Protein precipitation in sample wells often results from insufficient SDS or high salt content - adjust buffer composition accordingly; inadequate sample heating causes incomplete denaturation - ensure proper heating time and temperature; protein aggregation may occur - consider adding urea or other solubilizing agents; contamination of wells with polyacrylamide fragments - clean wells thoroughly before loading; improper loading technique causes spillover - use proper loading tips and technique.

  • Uneven Migration Across Gel

Uneven polymerization results from improper mixing of gel solution - mix thoroughly before pouring; temperature gradients during electrophoresis - ensure consistent temperature or use cooling; uneven buffer levels between chambers - check and adjust buffer volumes; electrical field distortion from buffer leaks - check apparatus for leaks; warped gel plates create uneven thickness - use properly leveled casting stand.

  • No Bands Visible

Insufficient protein loading requires concentration adjustment - increase sample volume or concentrate proteins; proteins not retained during staining - check staining protocol and timing; expired or improperly prepared staining reagents - use fresh solutions; protein degradation from protease activity - add protease inhibitors during sample preparation; proteins running off gel - select appropriate gel percentage for target molecular weight.

  • Ghost Bands

Carry-over contamination from previous samples requires thorough cleaning between runs; degradation products indicate proteolysis - add protease inhibitors and work quickly; non-specific staining of gel impurities - filter gel solutions before casting; artifacts from improper gel handling - use clean equipment and handle carefully; contaminated reagents or buffers - prepare fresh solutions under clean conditions.

  • Wavy Band Patterns

Trapped air bubbles during gel casting create uneven patterns - degas solutions and pour carefully; uneven polymerization from temperature variations - ensure consistent room temperature; electrical field disturbances from buffer discontinuities - check buffer composition and pH; mechanical vibration during run - place apparatus on stable surface; improper comb insertion causes gel distortion - insert comb straight and level.

  • Poor Staining

Insufficient staining time or incorrect concentration requires protocol optimization; SDS interference with dye binding - include destaining step to remove excess SDS; over-destaining removes protein-bound dye - monitor destaining process carefully; incompatibility between protein type and staining method - try alternative staining protocols; expired or improperly prepared staining solutions - use fresh reagents stored properly. Insufficient staining time or incorrect concentration requires protocol optimization; SDS interference with dye binding - include destaining step to remove excess SDS; over-destaining removes protein-bound dye - monitor destaining process carefully; incompatibility between protein type and staining method - try alternative staining protocols; expired or improperly prepared staining solutions - use fresh reagents stored properly.

Products with Tested Data

At Creative Biolabs, we are dedicated to providing high-quality antibodies for various research applications. Each product in our extensive range has been rigorously tested to ensure superior reliability and efficacy. To showcase the performance of our antibodies, we have conducted numerous experiments using SDS-PAGE. Below, you will find a table listing a selection of our antibody products along with images from these SDS-PAGE experiments, demonstrating their proven reliability.

Product Name Catalog Number Target Image Description
Mouse Anti-Psa Recombinant Antibody; Fab Fragment (HPAB-3383LY-F(E)) HSP90AB1 Psa
SDS-PAGE analysis of HPAB-3383LY-F(E) in non-reduced (Lane 1) and reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins migrate as about 25 kDa. And non-reduced protein migrates as 50 kDa.
Human Anti-PCSK9 Recombinant Antibody (HPAB-667-FY) IκB β PCSK9
SDS-PAGE analysis of HPAB-667-FY in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Human Anti-CD4 Recombinant Antibody (HPAB-J0050-YC) H3F3A (Tri Methyl Lys79) CD4
SDS-PAGE analysis of HPAB-J0050-YC in reduced (Lane 1) and non-reduced (Lane 2) conditions.
Mouse Anti-FSTL3 Recombinant Antibody (HPAB-N0094-YC) HSP70 FSTL3
SDS-PAGE analysis of HPAB-N0094-YC in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Human Anti-GPIb Recombinant Antibody (clone HIb-6) H3F3A GPIb
SDS-PAGE analysis of HPAB-S0057-YC in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Human Anti-HLA-A2-Mart-1 Complex Recombinant Antibody (clone CLA12) CASP3 HLA-A2-Mart-1 Complex
SDS-PAGE analysis of HPAB-N0135-YC in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Recombinant Human Anti-DENV E proteins Antibody (PABL-065) LC3A DENV E proteins
SDS-PAGE analysis of PABL-065 in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.
Mouse Anti-DOTA Recombinant Antibody (HPAB-1251WJ) LTF DOTA
SDS-PAGE analysis of HPAB-1251WJ in non-reduced (Lane1) and β-mercaptoethanol-reduced conditions (Lane2).
Mouse Anti-SEZ6 Recombinant Antibody (HPAB-AP167-YC) Kif 7 SEZ6
SDS-PAGE analysis of HPAB-AP167-YC in non-reduced (Lane 2) and reduced (Lane 1) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Human Anti-TPO Recombinant Antibody (clone TR1.9) MKI67 TPO
Lane M: Protein Marker Lane 1: Reducing mAb
Recombinant Mouse Anti-HBV preS2 Antibody (F124) LMNB1 HBV preS2
Lane 1: Non-reduced
Lane 2: Reduced
Recombinant Human Anti-DENV E proteins Antibody (5J7) DDX5 DENV E proteins
SDS-PAGE analysis of PABL-067 in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.
Rabbit Anti-Hypusine Recombinant Antibody (PABL-202) TP53 Hypusine
Lane 1: Reducing mAb Lane 2: Non-Reducing mAb
Recombinant Human Anti-IAV HA Antibody (CT149) PRKDC IAV HA
SDS-PAGE analysis of PABL-213 in non-reduced (Lane 1, 2 μg) and β-mercaptoethanol-reduced (Lane 2, 2 μg) conditions.
Mouse Anti-Human CD22 Recombinant Antibody RAF1 CD22 (Cluster of differentiation 22)
SDS-PAGE analysis of TAB-003LC in non-reduced and β-mercaptoethanol-reduced conditions.
Anti-Human CD44 Recombinant Antibody (RG7356) Luciferase CD44
SDS-PAGE analysis of TAB-128CL in non-reduced and β-mercaptoethanol-reduced conditions.
Human Anti-GPC3 Recombinant Antibody; Fab Fragment (TAB-157CT-F(E)) MICU1 GPC3
SDS-PAGE analysis of TAB-157CT-F(E) in non-reduced and β-mercaptoethanol-reduced conditions.
Mouse Anti-Tau Recombinant Antibody (TAB-522CT) ERBB3 Tau
SDS-PAGE analysis of TAB-522CT in non-reduced and β-mercaptoethanol-reduced conditions.
Mouse Anti-FCRL5 Recombinant Antibody (HPAB-AP650-YC) RPS27 FCRL5
SDS-PAGE analysis of HPAB-AP650-YC in non-reduced (lane 2) and β-mercaptoethanol-reduced (lane 1) conditions.
Mouse Anti-SEZ6 Recombinant Antibody (HPAB-AP163-YC) ATG5 SEZ6
SDS-PAGE analysis of HPAB-AP163-YC in non-reduced (Lane 2) and reduced (Lane 1) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Anti-Human CD276 Recombinant Antibody (TAB-117CL) ATG7 CD276
SDS-PAGE analysis of TAB-117CL in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.
Recombinant Human Anti-IAV HA Antibody (5J8) RTN3 IAV HA
SDS-PAGE analysis of PABL-207 in non-reduced and reduced conditions.
Human Anti-MS4A1 Recombinant Antibody (clone 2F2) RTN1 MS4A1
Lane 1: Non-reduced
Lane 2: Reduced
Human Anti-GREM1 Recombinant Antibody (TAB-007CT) NEFM GREM1
SDS-PAGE analysis of TAB-007CT in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.
Human Anti-CD3E Recombinant Antibody (TAB-124CL) VIM CD3E
SDS-PAGE analysis of TAB-124CL in non-reduced and β-mercaptoethanol-reduced conditions.
Mouse Anti-SNCA Recombinant Antibody (TAB-0750CLV) ACTA2 Alpha-synuclein
SDS-PAGE analysis of TAB-0750CLV in non-reduced (Lane 1) and reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Anti-Human IL5RA Recombinant Antibody (TAB-222) ENO2 IL5RA
SDS-PAGE analysis of TAB-222 in non-reduced (Lane 1) and reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Mouse Anti-KIT Recombinant Antibody (clone 79D) MAP2 KIT
SDS-PAGE analysis of PABL-642 in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Human Anti-TMEM30A Recombinant Antibody (PABL-712CQ) α skeletal muscle actin TMEM30A
SDS-PAGE analysis of PABL-712CQ in non-reduced and β-mercaptoethanol-reduced conditions.
Rabbit Anti-SNCA Recombinant Antibody (TAB-0740CLV) CASP8 Alpha-synuclein
SDS-PAGE analysis of TAB-0740CLV in non-reduced and β-mercaptoethanol-reduced conditions.
Anti-Human PERP Recombinant Antibody (KM3411) KRT8 PERP (p53 apoptosis effector related to PMP-22)
SDS-PAGE analysis of TAB-1017CL in non-reduced (Lane 1) and reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Human Anti-TSHR Recombinant Antibody (clone K1-70) XRCC4 TSHR
SDS-PAGE analysis of PABL-737 in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as about 180-245 kDa.
Human Anti-IL20 Recombinant Antibody (TAB-0009CL) α-SMA IL20
SDS-PAGE analysis of TAB-0009CL in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Human Anti-GPC3 Recombinant Antibody; Fab Fragment (TAB-158CT-F(E)) MyHCs GPC3
SDS-PAGE analysis of TAB-158CT-F(E) in non-reduced and β-mercaptoethanol-reduced conditions.
Human Anti-TREM1 Recombinant Antibody; scFv Fragment (TAB-167CQ-S(P)) EGFR Triggering receptor expressed on myeloid cells-1
SDS-PAGE analysis of TAB-167CQ-S(P) in reduced (Lane 1) and non-reduced (Lane 2) conditions.
Anti-Human IL17RA Recombinant Antibody (TAB-217) DES IL17RA
SDS-PAGE analysis of TAB-217 in non-reduced (Lane 1, 2.5ug) and reduced (Lane 2, 2.5ug) conditions.
Mouse Anti-FCRL5 Recombinant Antibody (MOB-056CQ) HAO1 FCRL5
SDS-PAGE analysis of MOB-056CQ in non-reduced (lane 2) and β-mercaptoethanol-reduced (lane 1) conditions.
Anti-Human Abeta Recombinant Antibody (Solanezumab) TUBE1 Abeta
SDS-PAGE analysis of TAB-228 in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions.
Mouse Anti-GDF15 Recombinant Antibody (HPAB-0344-CN) MAPK3 GDF15
SDS-PAGE analysis of HPAB-0344-CN in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Recombinant Human Anti-HSV Antibody (AC8) LGALS3 HSV
SDS-PAGE analysis of HPAB-J0123-YC in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Human Anti-SA Recombinant Antibody (HPAB-2545LY) NBR1 serum albumin
SDS-PAGE analysis of HPAB-2545LY in non-reduced (lane 2) and reduced (lane 1) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Mouse Anti-MRC2 Recombinant Antibody (HPAB-M0694-YC) GAPDH MRC2
SDS-PAGE analysis of HPAB-M0694-YC in reduced (Lane 1) and non-reduced (Lane 2) conditions.
Mouse Anti-EREG Recombinant Antibody (clone 9E5) HIST1H2BB EREG
SDS-PAGE analysis of PABL-084 in non-reduced (Lane 1, 2 μg) and reduced (Lane 2, 2 μg) conditions.
Recombinant Mouse Anti-B. burgdorferi OspA Antibody ( LA-2) RELA B. burgdorferi OspA
SDS-PAGE analysis of PABZ-012 in reduced (Lane 1) and non-reduced (Lane 2) conditions.
Human Anti-MERS-CoV S Recombinant Antibody (MRO-887LC) ERBB2 S protein
SDS-PAGE analysis of MRO-887LC in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Human Anti-PIV3 Prefusion Recombinant Antibody Fab Fragment (PABJ-0161-F(E)) LacZ PIV3 Prefusion
SDS-PAGE analysis of PABJ-0161-F(E) in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Anti-Human IFNG Recombinant Antibody (Fontolizumab) LAMC1 IFNG
SDS-PAGE analysis of TAB-041 in non-reduced (Lane 2) and reduced (Lane 1) conditions.
Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) Cardiotin CD22
SDS-PAGE analysis of TAB-183-F(E) in non-reduced (Lane 1). Gel stained for 30 minutes with Coomassie Blue. And non-reduced protein migrates as 70 kDa.
Anti-Influenza A Virus (H1N1/H2N2) HA Recombinant Antibody (C179) RPA2 HA
SDS-PAGE analysis of MRO-248LC in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Mouse Anti-gB glycoprotein Recombinant Antibody (MRO-960LC) SKP2 gB glycoprotein
SDS-PAGE analysis of MRO-960LC in reduced (Lane 1) and non-reduced (Lane 2) conditions.
References
  1. Bhatt, Mukesh, et al. "SDS-PAGE and Western blotting: Basic principles and protocol." Protocols for the Diagnosis of Pig Viral Diseases. New York, NY: Springer US, 2022. 313-328.
  2. Gallagher, Sean R. "SDS‐polyacrylamide gel electrophoresis (SDS‐PAGE)." Current protocols essential laboratory techniques 1 (2008): 7-3.

For research use only. Not intended for any clinical use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare